Výsledky vyhledávání

Akademický článek

High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018.

Autor: Stefanos R; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA., Lewis RM; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Querec TD; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Gargano JW; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Unger ER; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Markowitz LE; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2308378. Date of Electronic Publication: 2024 Feb 19.

Zobrazit plný text záznamu

Akademický článek

Vaccine effectiveness against anal HPV among men who have sex with men aged 18-45 years attending sexual health clinics in three United States cities, 2018-2023.

Autor: DeSisto CL; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Winer RL; Department of Epidemiology, University of Washington, Seattle, WA, USA., Querec TD; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Dada D; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Pathela P; New York City Department of Health and Mental Hygiene, New York City, NY, USA., Asbel L; Philadelphia Department of Public Health, Philadelphia, PA, USA., Lin J; Department of Epidemiology, University of Washington, Seattle, WA, USA., Tang J; New York City Department of Health and Mental Hygiene, New York City, NY, USA., Iqbal A; Seattle and King County Public Health Lab, Seattle, WA, USA., Meites E; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Unger ER; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Markowitz LE; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.

Zobrazit plný text záznamu

Akademický článek

Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.

Autor: Prétet JL; French National Papillomavirus Reference Center, CHU de Besançon, EA3181, Université of Franche-Comté, F-25000 Besançon, France., Arroyo Mühr LS; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden., Cuschieri K; Scottish HPV Reference Laboratory, Deptartment of Lab Medicine, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, UK., Fellner MD; Laboratorio Nacional y Regional de Referencia de Papilomavirus Humanos, Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr Malbrán', C1282AFF Buenos Aires, Argentina., Correa RM; Laboratorio Nacional y Regional de Referencia de Papilomavirus Humanos, Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr Malbrán', C1282AFF Buenos Aires, Argentina., Picconi MA; Laboratorio Nacional y Regional de Referencia de Papilomavirus Humanos, Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr Malbrán', C1282AFF Buenos Aires, Argentina., Garland SM; Royal Women's Hospital, Parkville 3052 VIC, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Parkville 3052 VIC, Australia., Murray GL; Royal Women's Hospital, Parkville 3052 VIC, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Parkville 3052 VIC, Australia., Molano M; Royal Women's Hospital, Parkville 3052 VIC, Australia., Peeters M; National Reference Centre for Human Papillomaviruses, Viral Diseases, Infectious Diseases in Humans, Sciensano. Rue Juliette Wytsman 14, 1050 Brussels, Belgium., Van Gucht S; National Reference Centre for Human Papillomaviruses, Viral Diseases, Infectious Diseases in Humans, Sciensano. Rue Juliette Wytsman 14, 1050 Brussels, Belgium., Lambrecht C; National Reference Centre for Human Papillomaviruses, Algemeen Medisch Laboratorium. Emiel Vloorsstraat 9, 2020 Antwerp, Belgium., Broeck DV; National Reference Centre for Human Papillomaviruses, Algemeen Medisch Laboratorium. Emiel Vloorsstraat 9, 2020 Antwerp, Belgium., Padalko E; National Reference Centre for Human Papillomaviruses, Laboratory of Medical Microbiology, University Hospital Ghent. C. Heymanslaan 10, 9000 Ghent, Belgium., Arbyn M; Unit Cancer Epidemiology, Cancer centre, Sciensano. Rue Juliette Wytsman 14, 1050 Brussels, Belgium., Lepiller Q; French National Papillomavirus Reference Center, CHU de Besançon, EA3181, Université of Franche-Comté, F-25000 Besançon, France., Brunier A; French National Papillomavirus Reference Center, CHU de Besançon, EA3181, Université of Franche-Comté, F-25000 Besançon, France., Silling S; Institute of Virology, National Reference Center for Papilloma- and Polyomaviruses, University of Cologne, Faculty of Medicine and University Hospital of Cologne, 50935 Cologne, Germany., Søreng K; Norwegian HPV Reference Laboratory, Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway., Christiansen IK; Norwegian HPV Reference Laboratory, Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway., Poljak M; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška 4, 1000 Ljubljana, Slovenia., Lagheden C; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden., Yilmaz E; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden., Eklund C; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden., Thapa HR; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Querec TD; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Unger ER; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Dillner J; Swedish National HPV Reference Laboratory, Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital F56, 141 86 Stockholm, Sweden. Electronic address: Joakim.dillner@ki.se.

Publikováno v: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Apr; Vol. 171, pp. 105657. Date of Electronic Publication: 2024 Feb 20.

Zobrazit plný text záznamu

Akademický článek

Human Papillomavirus Detection in Scrotal Squamous Cell Carcinoma: Case Series from a Population-Based Cancer Registry.

Autor: Mix JM; Centers for Disease Control and Prevention, Atlanta, Georgia.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee., Miller MJ; Centers for Disease Control and Prevention, Atlanta, Georgia., Querec TD; Centers for Disease Control and Prevention, Atlanta, Georgia., Darragh TM; University of California, San Francisco, Department of Pathology, San Francisco, California., Saraiya M; Centers for Disease Control and Prevention, Atlanta, Georgia., Gopalani SV; Centers for Disease Control and Prevention, Atlanta, Georgia.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee., Lynch CF; University of Iowa, Iowa City, Iowa., Thompson TD; Centers for Disease Control and Prevention, Atlanta, Georgia., Greek A; Battelle, Seattle, Washington., Tucker TC; College of Public Health, University of Kentucky, Lexington, Kentucky., Peters ES; School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana., Unger ER; Centers for Disease Control and Prevention, Atlanta, Georgia.

Publikováno v: Journal of registry management [J Registry Manag] 2023 Winter; Vol. 50 (4), pp. 116-121.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání